BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11306392)

  • 1. Disappearance of well-differentiated carcinoma of the prostate: effect of transurethral resection of the prostate, prostate-specific antigen, and prostate biopsy.
    Endrizzi J; Optenberg S; Byers R; Thompson IM
    Urology; 2001 Apr; 57(4):733-6. PubMed ID: 11306392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostate cancer development after transurethral resection of the prostate--histopathological studies of radical prostatectomy specimens].
    Kanno H; Umemoto S; Izumi K; Hasumi H; Osada Y; Ohta J; Mikata K; Tuchiya F
    Nihon Hinyokika Gakkai Zasshi; 2006 May; 97(4):649-59. PubMed ID: 16768146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screening.
    Mai KT; Isotalo PA; Green J; Perkins DG; Morash C; Collins JP
    Arch Pathol Lab Med; 2000 Oct; 124(10):1454-6. PubMed ID: 11035574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental detection of population-based prostate cancer incidence rates through transurethral resection of the prostate.
    Merrill RM; Wiggins CL
    Urol Oncol; 2002; 7(5):213-9. PubMed ID: 12644219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application value of diagnostic TURP for patients with serum PSA abnormality].
    Yuan J; Zhao H; Wu B
    Zhonghua Nan Ke Xue; 2013 Nov; 19(11):999-1002. PubMed ID: 24341094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Huber A; Lümmen G; Tscholl R
    Urology; 2000 Apr; 55(4):481-5. PubMed ID: 10736487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of transrectal ultrasound-guided biopsy of the prostate and transurethral resection of the prostate for detection of prostate cancer in patients with moderate lower urinary tract symptoms.
    Chen SS; Chiu LP; Chen KK
    J Chin Med Assoc; 2010 Nov; 73(11):568-72. PubMed ID: 21093824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
    Jones JS; Follis HW; Johnson JR
    Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
    Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
    Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of transurethral resection of the prostate in population-based prostate cancer incidence rates.
    Merrill RM; Feuer EJ; Warren JL; Schussler N; Stephenson RA
    Am J Epidemiol; 1999 Oct; 150(8):848-60. PubMed ID: 10522656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
    Hara N; Koike H; Nobushita T; Miyajima N; Kawaguchi M; Nishiyama T; Takahashi K; Hohenfellner R
    Urol Oncol; 2010; 28(4):355-9. PubMed ID: 19110451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.
    Schröder FH; Roobol-Bouts M; Vis AN; van der Kwast T; Kranse R
    Urology; 2001 Jan; 57(1):83-90. PubMed ID: 11164149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass screening of 12,027 elderly men for prostate carcinoma by measuring serum prostate specific antigen.
    Zhang HF; Wang HL; Xu N; Li SW; Ji GY; Li XM; Pan YZ; Zhang L; Zhao XJ; Gao HW
    Chin Med J (Engl); 2004 Jan; 117(1):67-70. PubMed ID: 14733776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should men with serum prostate-specific antigen < or =4 ng/ml and normal digital rectal examination undergo a prostate biopsy? A literature review.
    Pepe P; Panella P; D'Arrigo L; Savoca F; Pennisi M; Aragona F
    Oncology; 2006; 70(2):81-9. PubMed ID: 16601365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of prior TURP on radical prostatectomy surgical margins: a multicenter analysis.
    Gacci M; Simonato A; Lanciotti M; Ennas M; Varca V; Maffezzini M; Imbimbo C; Gontero P; Schiavina R; Carini M; Martorana G; Nicita G; Mirone V; Carmignani G
    Urol Int; 2013; 91(1):62-8. PubMed ID: 23735440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
    Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
    BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
    Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
    Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients.
    Mosli HA; Abdel-Meguid TA; Al-Maghrabi JA; Kamal WK; Saadah HA; Farsi HM
    Saudi Med J; 2009 Nov; 30(11):1439-43. PubMed ID: 19882057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does screening for prostate cancer identify clinically important disease?
    Feneley MR
    Ann R Coll Surg Engl; 1999 May; 81(3):207-14. PubMed ID: 10364958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.